搜尋結果
Acuitas, CureVac settle lawsuit over COVID-19 vaccine patent rights
Reuters· 6 小時前Biotech company Acuitas Therapeutics and Germany-based CureVac have settled Acuitas' ...
S&P 500 futures pop in overnight trading, boosted by Alphabet and Microsoft: Live updates
CNBC· 6 小時前Stock futures rose in overnight trading Thursday as Big Tech names Alphabet and Microsoft saw ...
U.S. GDP Report’s Inflation Data Makes It Harder for Fed to Cut Rates - What’s News - WSJ Podcasts
The Wall Street Journal· 7 小時前P.M. Edition for April 25. Gross domestic product expanded at a 1.6% seasonally- and ...
Rubrik's shares end trading up almost 16% on the company's public debut
TechCrunch· 7 小時前Rubrik shares hit the New York Stock Exchange Thursday, debuting at $38 a share. Rubrik sells cloud-based security software ...
Here’s a full recap of CNBC’s 2024 Stock Draft: Charlotte Flair likes IBM, Eddie George picks Apple
CNBC· 8 小時前The annual stock-picking competition pits financial professionals, athletes and celebrities ...
Colombia becomes first country to restrict US beef due to bird flu in dairy cows
Reuters· 9 小時前Department of Agriculture. It is the first country to officially limit trade in beef due to ...
Paramount and Skydance inch closer to a merger as key hurdle looms, sources say
CNBC· 9 小時前Paramount Global and Skydance Media are making progress on a deal that would merge the media ...
Can a new batch of tech earnings rescue the market? Here are the factors at play
CNBC· 9 小時前There have been plenty of earnings beats in the past 24 hours, but the lack of raises to the ...
Microsoft-backed Rubrik's stock jumps 21% in NYSE debut
Reuters· 10 小時前Rubrik's shares climbed nearly 21% in their debut on the New York Stock Exchange on ...
Dow closes lower by more than 370 points as inflation, growth worries resurface: Live updates
CNBC· 14 小時前The lackluster GDP added further pressure to an already-tense market contending with concerns ...